4//SEC Filing
Baumal Caroline 4
Accession 0001127602-25-001011
CIK 0001492422other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:03 PM ET
Size
4.5 KB
Accession
0001127602-25-001011
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-01-06$33.81/sh−2,816$95,215→ 55,560.37 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/03/2025.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001961100
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:03 PM ET
- Size
- 4.5 KB